[go: up one dir, main page]

AU2001233063A1 - Vaccination of hiv infected persons following highly active antiretroviral therapy - Google Patents

Vaccination of hiv infected persons following highly active antiretroviral therapy

Info

Publication number
AU2001233063A1
AU2001233063A1 AU2001233063A AU3306301A AU2001233063A1 AU 2001233063 A1 AU2001233063 A1 AU 2001233063A1 AU 2001233063 A AU2001233063 A AU 2001233063A AU 3306301 A AU3306301 A AU 3306301A AU 2001233063 A1 AU2001233063 A1 AU 2001233063A1
Authority
AU
Australia
Prior art keywords
vaccination
highly active
hiv infected
antiretroviral therapy
infected persons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233063A
Inventor
Raphaelle El Habib
David Ho
Michel Klein
Martin Markowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Aaron Diamond AIDS Research Center
Original Assignee
Aventis Pasteur SA
Aaron Diamond AIDS Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA, Aaron Diamond AIDS Research Center filed Critical Aventis Pasteur SA
Publication of AU2001233063A1 publication Critical patent/AU2001233063A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001233063A 2000-01-31 2001-01-26 Vaccination of hiv infected persons following highly active antiretroviral therapy Abandoned AU2001233063A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17927600P 2000-01-31 2000-01-31
US60/179,276 2000-01-31
PCT/US2001/002766 WO2001054701A1 (en) 2000-01-31 2001-01-26 Vaccination of hiv infected persons following highly active antiretroviral therapy

Publications (1)

Publication Number Publication Date
AU2001233063A1 true AU2001233063A1 (en) 2001-08-07

Family

ID=22655900

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233063A Abandoned AU2001233063A1 (en) 2000-01-31 2001-01-26 Vaccination of hiv infected persons following highly active antiretroviral therapy

Country Status (2)

Country Link
AU (1) AU2001233063A1 (en)
WO (1) WO2001054701A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1980617A1 (en) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Improved expression of HIV polypeptides and production of virus-like particles
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CN101076247A (en) * 2003-09-18 2007-11-21 默克公司 Therapeutic immunization of HIV-infected individuals
AU2005335203A1 (en) 2004-09-08 2007-02-15 The United States Of America As Represented By The Secretary Of Health And Human Services, Nih Compositions and methods for the detection of HIV-1/HIV-2 infection
EP2477651A1 (en) * 2009-09-17 2012-07-25 Sanofi Pasteur Inc. Immunological compositions for hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008539A1 (en) * 1996-08-26 1998-03-05 Chiron Corporation Postinfection human immunodeficiency virus (hiv) vaccination therapy
WO2001008702A2 (en) * 1999-07-28 2001-02-08 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Immunotherapy in hiv infected persons using vaccines after multi-drug treatment

Also Published As

Publication number Publication date
WO2001054701A9 (en) 2002-10-31
WO2001054701A1 (en) 2001-08-02

Similar Documents

Publication Publication Date Title
AU2001261198A1 (en) Patient point of care computer system
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
AU1167602A (en) Methods of therapy for hiv infection
IL150961A0 (en) Human immunodeficiency virus vaccine
AU2001241918A1 (en) Methods of enhancing activity of vaccines and vaccine compositions
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2001238501A1 (en) Selective destruction of cells infected with human immunodeficiency virus
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU4088697A (en) Postinfection human immunodeficiency virus (hiv) vaccination therapy
AU2001233063A1 (en) Vaccination of hiv infected persons following highly active antiretroviral therapy
AU2002210407A1 (en) Therapeutic vaccine formulations containing chitosan
AU2002331599A1 (en) Epitopes of human immunodeficiency virus-1
AU2003210659A1 (en) Combination therapy for treatment of hiv infection
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU2001258785A1 (en) Sterilization of silicone preparations
AU2002343146A1 (en) Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections
AU2002364163A1 (en) USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2002252610A1 (en) Ultrasonic profiling of medicament administration into tissue
AU2960000A (en) Detection of human immunodeficiency virus
WO2002007760A3 (en) Therapeutic agent against aids comprising anti hiv goat antibody
AU2002360523A1 (en) Compounds to treat hiv infection and aids
AU2002322424A1 (en) Novel methods and formulations for administration of active agents
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection